Financial reports
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
15 Nov 22
NT 10-Q
Notice of late quarterly filing
15 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
7 Mar 24
8-K
Departure of Directors or Certain Officers
6 Nov 23
8-K
Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022; Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results
9 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 23
8-K
Nephros Announces CEO Retirement and Succession Plan
11 May 23
8-K
Nephros Announces Preliminary Results for First Quarter 2023
4 Apr 23
8-K
Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
8 Mar 23
8-K
Departure of Directors or Certain Officers
3 Feb 23
8-K
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022
11 Jan 23
8-K
Unaudited Pro Forma Condensed Consolidated Financial Statements
21 Nov 22
Registration and prospectus
424B3
Prospectus supplement
15 Sep 21
S-3
Shelf registration
7 Sep 21
D/A
$2.44M in securities to be acquired, sold $2.1M, 19 investors
7 Sep 21
D
$1.2M in equity, sold $1.2M, 1 investor
14 Jul 21
S-8
Registration of securities for employees
2 Jun 21
424B5
Prospectus supplement for primary offering
16 Oct 20
D/A
$2.44M in securities to be acquired, sold $2M, 19 investors
4 Sep 20
S-8
Registration of securities for employees
21 May 20
424B3
Prospectus supplement
10 Apr 20
424B5
Prospectus supplement for primary offering
31 Jan 20
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEF 14A
Definitive proxy
13 Apr 22
DEFA14A
Additional proxy soliciting materials
7 Apr 21
DEFA14A
Additional proxy soliciting materials
7 Apr 21
DEF 14A
Definitive proxy
7 Apr 21
DEFA14A
Additional proxy soliciting materials
11 May 20
DEF 14A
Definitive proxy
8 Apr 20
DEFA14A
Additional proxy soliciting materials
8 Apr 20
Other
EFFECT
Notice of effectiveness
15 Sep 21
CORRESP
Correspondence with SEC
10 Sep 21
UPLOAD
Letter from SEC
9 Sep 21
EFFECT
Notice of effectiveness
9 Dec 19
CORRESP
Correspondence with SEC
4 Dec 19
CORRESP
Correspondence with SEC
27 Nov 19
UPLOAD
Letter from SEC
14 Nov 19
EFFECT
Notice of effectiveness
16 Oct 19
EFFECT
Notice of effectiveness
16 Oct 19
CERT
Certification of approval for exchange listing
13 Aug 19